Key result
Mexiletine and lidocaine preferentially affected the gating of Nav1.5 compared to Nav1.7, with mexiletine exhibiting a stronger use-dependent block of Nav1.5 channels.
Answers are grounded in this paper and cite their sources.
Mexiletine exhibits stronger use-dependent block and prolongs recovery from inactivation of Nav1.5 channels compared to lidocaine, providing mechanistic insights into its anti-arrhythmic effectiveness.
Mexiletine and lidocaine are widely used class IB anti-arrhythmic drugs that are considered to act by blocking voltage-gated open sodium currents for treatment of ventricular arrhythmias and relief of pain. To gain mechanistic insights into action of anti-arrhythmics, we characterized biophysical properties of Nav1.5 and Nav1.7 channels stably expressed in HEK293 cells and compared their use-dependent block in response to mexiletine and lidocaine using whole-cell patch clamp recordings. While the voltage-dependent activation of Nav1.5 or Nav1.7 was not affected by mexiletine and lidocaine, the steady-state fast and slow inactivation of Nav1.5 and Nav1.7 were significantly shifted to hyperpolarized direction by either mexiletine or lidocaine in dose-dependent manner. Both mexiletine and lidocaine enhanced the slow component of closed-state inactivation, with mexiletine exerting stronger inhibition on either Nav1.5 or Nav1.7. The recovery from inactivation of Nav1.5 or Nav1.7 was significantly prolonged by mexiletine compared to lidocaine. Furthermore, mexiletine displayed a pronounced and prominent use-dependent inhibition of Nav1.5 than lidocaine, but not Nav1.7 channels. Taken together, our findings demonstrate differential responses to blockade by mexiletine and lidocaine that preferentially affect the gating of Nav1.5, as compared to Nav1.7; and mexiletine exhibits stronger use-dependent block of Nav1.5. The differential gating properties of Nav1.5 and Nav1.7 in response to mexiletine and lidocaine may help explain the drug effectiveness and advance in new designs of safe and specific sodium channel blockers for treatment of cardiac arrhythmia or pain.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2015) studied this question. Mexiletine and Lidocaine vs. Drug-free control was evaluated on Gating properties and use-dependent block of Nav1.5 and Nav1.7 channels. Mexiletine and lidocaine preferentially affected the gating of Nav1.5 compared to Nav1.7, with mexiletine exhibiting a stronger use-dependent block of Nav1.5 channels.
Synapse has enriched 10 related papers. Consider them for comparative context: